News & Events

In this section you will find Selcia news and up-coming events Selcia is attending. 

10 February 2017

Selcia, with colleagues from Cypralis and Gilead Sciences Inc., have published in the Journal of Medicinal Chemistry a novel strategy of structural simplification of a natural product to generate synthetically tractable cyclophilin inhibitors for the treatment of HCV. 

23 January 2017

Carol Austin, Associate Director of Discovery, who managed the project, said ‘Selcia’s unique expertise in the area of peptidyl prolyl isomerase screening and medicinal chemistry enabled Cypralis to achieve the milestones for this challenging project. We look forward to continuing to support Cypralis in achieving the goals of the Innovate UK Early Stage award’.

Cypralis issued this press release on 23rd January 2017; follow this link for the full version:

11 August 2016

Selcia’s unique compound fragment library is now available for purchase through BioAscent’s online Compound Cloud service. Selcia’s fragment collection of 1366 compounds has been designed in collaboration with Cambridge MedChem Consulting.